Literature DB >> 17655939

Neuronal NF-kappaB influences thermoregulation and survival in a sepsis model.

Eric Jüttler1, Ioana Inta, Verena Eigler, Oliver Herrmann, Ira Maegele, Christiane Maser-Gluth, Markus Schwaninger.   

Abstract

Gene regulation in sepsis is known to be controlled by the transcription factor NF-kappaB. However, the function of neuronal NF-kappaB in sepsis is not well defined. In a mouse model of sepsis induced by i.p. injection of lipopolysaccharides (LPS), we found an activation of NF-kappaB in the brain as shown by the induction of a transgenic NF-kappaB reporter. Inhibition of neuronal NF-kappaB by cell-specific expression of the NF-kappaB super-repressor IkappaBalpha-SR improved LPS-induced hypothermia and survival but had no effect on body weight or on the humoral response to LPS. In contrast, glial inhibition of NF-kappaB did not influence body temperature and survival. By immunohistochemistry, we detected the active NF-kappaB subunit RelA in neuronal nuclei of the organum vasculosum of the lamina terminalis. Our data reveal an important role of neuronal NF-kappaB in thermoregulation and survival. The upcoming group of NF-kappaB inhibitors may have a place in the treatment of the acute-phase response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655939     DOI: 10.1016/j.jneuroim.2007.06.020

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Cyclooxygenase-1 or -2--which one mediates lipopolysaccharide-induced hypothermia?

Authors:  Alexandre A Steiner; John C Hunter; Sean M Phipps; Tatiane B Nucci; Daniela L Oliveira; Jennifer L Roberts; Adrienne C Scheck; Daniel L Simmons; Andrej A Romanovsky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-10       Impact factor: 3.619

2.  Effects of adenosine A2a receptor agonist and antagonist on hippocampal nuclear factor-kB expression preceded by MDMA toxicity.

Authors:  Fatemeh Kermanian; Mansooreh Soleimani; Alireza Ebrahimzadeh; Hossein Haghir; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2012-12-06       Impact factor: 3.584

Review 3.  NF-kappaB in the nervous system.

Authors:  Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

4.  Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP technology.

Authors:  Subhash C Datta; Mark R Opp
Journal:  J Neurosci Methods       Date:  2008-08-14       Impact factor: 2.390

5.  Temperature variability analysis using wavelets and multiscale entropy in patients with systemic inflammatory response syndrome, sepsis, and septic shock.

Authors:  Vasilios E Papaioannou; Ioanna G Chouvarda; Nikos K Maglaveras; Ioannis A Pneumatikos
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

6.  Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS).

Authors:  Claudia Crosio; Cristiana Valle; Arianna Casciati; Ciro Iaccarino; Maria Teresa Carrì
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

7.  Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies.

Authors:  Miles Herkenham; Priyanka Rathore; Pierre Brown; Samuel J Listwak
Journal:  J Neuroinflammation       Date:  2011-10-14       Impact factor: 8.322

8.  Analysis of uncoupling protein 2-deficient mice upon anaesthesia and sedation revealed a role for UCP2 in locomotion.

Authors:  Marie-Clotilde Alves-Guerra; Caroline Aheng; Claire Pecqueur; Sandrine Masscheleyn; Pierre Louis Tharaux; Anne Druilhe; Daniel Ricquier; Etienne Challet; Bruno Miroux
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

Review 9.  NF-KappaB in Long-Term Memory and Structural Plasticity in the Adult Mammalian Brain.

Authors:  Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  Front Mol Neurosci       Date:  2015-11-24       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.